Glycopyrrolate NDC 70518-4537

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4537Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4537Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-4537-0	70518453700	100 POUCH in 1 BOX (70518-4537-0) / 1 TABLET in 1 POUCH (70518-4537-1)Marketed from Dec 17, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glycopyrrolate
Generic name (nonproprietary): glycopyrrolate
Active ingredients: Glycopyrrolate — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212696
Marketing start: Dec 17, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 70518-4537_5b9bdb65-2322-b56c-e063-6394a90a4c28SPL ID 5b9bdb65-2322-b56c-e063-6394a90a4c28
Pharmacologic class: Anticholinergic; Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518453700 followed by a unit qualifier and the quantity

Package 70518-4537-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 212696

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212696
Product	Strength	Form · route	Labeler	Product NDC
Glycopyrrolate	Glycopyrrolate 1 mg/1	TabletOral	QUAGEN PHARMACEUTICALS LLC	70752-108
Glycopyrrolate	Glycopyrrolate 2 mg/1	TabletOral	QUAGEN PHARMACEUTICALS LLC	70752-109
Glycopyrrolate	Glycopyrrolate 1 mg/1	TabletOral	Bryant Ranch Prepack	72162-2597
Glycopyrrolate	Glycopyrrolate 2 mg/1	TabletOral	Bryant Ranch Prepack	72162-2598